COSCIENS Biopharma named Peter Puccetti interim chief executive officer after Anna Biehn stepped down from the role, effective immediately. Puccetti, who will remain chairman of the Canadian ...

Closely held Purdue Pharma won bankruptcy court approval for an opioid-related settlement of at least $7.4 billion, clearing a path for the OxyContin maker to exit its six-year bankruptcy and resolve ...

After the opening bell rang in New York Friday, shares in Nvidia, Oracle and other companies at the heart of the ...

Risk-off sentiment dominated crypto markets this week, but some analysts contend the market rout is a healthy correction. Bitcoin traded at $94,263 as of 4 p.m. ET on Friday, its lowest 4 p.m. level ...

AI stocks were again at the center of the action, a day after dragging Wall Street to one of its worst drops since its ...

The Nasdaq marked its biggest intraday comeback since April as Wall Street bought the dip in some key technology and artificial intelligence stocks.

Despite negative futures, markets showed mixed performance by the close. The Dow fell 144 points to 47,312. The S&P 500 ...

The Nasdaq snapped a three-day losing streak with its biggest intraday rally since April, while the Dow lost triple digits ...

The U.S. stock market closed mostly lower Friday, with the S&P 500 giving up its gains shortly before the closing bell. The Dow Jones Industrial Average fell 0.7%, according to preliminary data from ...

The “Boom vs. Bubble” debate over Artificial Intelligence (AI) is getting louder. At the same time, money is rotating out of ...

The U.S. stock market continues to shake a day after one of its worst drops since its springtime sell-off. The S&P 500 fell 0 ...

An early swoon shook the U.S. stock market, but it quickly calmed. After starting Friday with a sharp drop of 1.3%, the S&P 500 erased all of it before ending ...